PETER S GARCIA
CIK 1188956 · CHIEF FINANCIAL OFFICER · last filed 2025-09-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$192.0K
Companies
6
Total Filings
47
Lifetime Open-Market Net
-$6.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DURECT CORP (DRRX) Delisted | Director | 0 | $1.91 | $0 | $0 | 6 | 2025-09-12 |
| ALXO | CHIEF FINANCIAL OFFICER | 121,516 | $1.58 | $192.0K | -$6.31M | 19 | 2024-08-16 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Vice President, CFO | 225,029 | — | — | $248.3K | 16 | 2019-04-16 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Chief Financial Officer | 7,000 | — | — | $31.7K | 3 | 2013-02-22 |
| Adhera Therapeutics, Inc. (MRNAD) Delisted | Chief Financial Officer | 5,000 | — | — | $0 | 2 | 2011-08-29 |
| MRNA | Chief Financial Officer | — | $49.91 | — | $0 | 1 | 2009-07-15 |
Recent Filings · Page 4 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-12-19 | PDL BIOPHARMA, INC. (PDLI) Delisted | Disp (D) | −17,818 | $0 | EDGAR |
| 2017-03-27 | PDL BIOPHARMA, INC. (PDLI) Delisted | Buy (P) | +25,000 | $49.4K | EDGAR |
| 2017-03-07 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +212,669 | $433.8K | EDGAR |
| 2016-12-15 | PDL BIOPHARMA, INC. (PDLI) Delisted | Disp (D) | −1,919 | $0 | EDGAR |
| 2016-08-10 | PDL BIOPHARMA, INC. (PDLI) Delisted | Buy (P) | +10,000 | $29.9K | EDGAR |
| 2016-01-28 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +101,051 | $325.4K | EDGAR |
| 2015-12-16 | PDL BIOPHARMA, INC. (PDLI) Delisted | Buy (P) | +15,000 | $52.4K | EDGAR |
| 2015-10-05 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +15,169 | $75.1K | EDGAR |
| 2015-08-17 | PDL BIOPHARMA, INC. (PDLI) Delisted | Buy (P) | +20,000 | $116.5K | EDGAR |
| 2015-01-30 | PDL BIOPHARMA, INC. (PDLI) Delisted | Grant (A) | +32,847 | $250.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.